Skip to main content
SpringerLink
Log in

Prucalopride: no increased risk of cardiovascular events

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Gilsenan A, et al. Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort Study. Drug Safety : 27 May 2019. Available from: URL: http://doi.org/10.1007/s40264-019-00835-0

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Prucalopride: no increased risk of cardiovascular events. Reactions Weekly 1757, 13 (2019). https://doi.org/10.1007/s40278-019-63241-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-63241-z

Search

Navigation